120 related articles for article (PubMed ID: 38007774)
1. Molecular Mechanism Analysis of Protopine Against Triple Negative Breast Cancer.
Chen T; Jiang H; Hu G; Acma FM; Huang B
Stud Health Technol Inform; 2023 Nov; 308():480-486. PubMed ID: 38007774
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology.
Li M; Zhao Y; Li H; Kang S; Deng X; Sheng M
Aging (Albany NY); 2024 Feb; 16(3):2848-2865. PubMed ID: 38329441
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology.
Chu M; Meng T; Zhou Y; Jin L; Dai Q; Ma L; Chen H
Medicine (Baltimore); 2023 Sep; 102(35):e34763. PubMed ID: 37657065
[TBL] [Abstract][Full Text] [Related]
5. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of Marsdenia tenacissima against ovarian cancer based on network pharmacology and experimental verification].
Hu YJ; Wei LY; Zhao J; Zhu QF; Meng ZY; Meng JJ; Chen JJ; Xu LY; Zhou YY; Han YL
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2222-2232. PubMed ID: 37282910
[TBL] [Abstract][Full Text] [Related]
7. Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer.
Zhao M; Fu L; Xu P; Wang T; Li P
Drug Des Devel Ther; 2023; 17():901-917. PubMed ID: 36998242
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments.
Chen L; Yang A; Li Y; Liu X; Jiang W; Hu K
Medicine (Baltimore); 2023 Sep; 102(37):e34835. PubMed ID: 37713894
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of active components of "Notoginseng Radix et Rhizoma-Drynariae Rhizoma" in treatment of osteoporosis based on network pharmacology and in vitro cell experiment].
Yang WJ; Huang J; Wang W; Peng LJ; Li JY; Zhu WF
Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(4):1087-1097. PubMed ID: 36872279
[TBL] [Abstract][Full Text] [Related]
10. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway.
Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J
Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857
[TBL] [Abstract][Full Text] [Related]
11. Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification.
Deng Z; Chen G; Shi Y; Lin Y; Ou J; Zhu H; Wu J; Li G; Lv L
Front Pharmacol; 2022; 13():920514. PubMed ID: 36003508
[No Abstract] [Full Text] [Related]
12. A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer.
Qayoom H; Alkhanani M; Almilaibary A; Alsagaby SA; Mir MA
Med Oncol; 2023 Jun; 40(7):202. PubMed ID: 37308611
[TBL] [Abstract][Full Text] [Related]
13. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
14. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
15. Systematic Evaluation of the Mechanisms of Mulberry Leaf (Morus alba Linne) Acting on Diabetes Based on Network Pharmacology and Molecular Docking.
Wu Q; Hu Y
Comb Chem High Throughput Screen; 2021; 24(5):668-682. PubMed ID: 32928080
[TBL] [Abstract][Full Text] [Related]
16. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
17. Exploring the mechanism of curcumin in the treatment of colon cancer based on network pharmacology and molecular docking.
He Q; Liu C; Wang X; Rong K; Zhu M; Duan L; Zheng P; Mi Y
Front Pharmacol; 2023; 14():1102581. PubMed ID: 36874006
[No Abstract] [Full Text] [Related]
18. Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics.
Geng X; Chi W; Lin X; Niu Z; Jiang Q; Sui Y; Jiang J
Medicine (Baltimore); 2023 Mar; 102(13):e33384. PubMed ID: 37000102
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.
Yuan Q; Zheng L; Liao Y; Wu G
World J Surg Oncol; 2021 Mar; 19(1):86. PubMed ID: 33757543
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]